STING1 and STING-associated vasculopathy with onset in infancy: The patients were aged 5 to 12 years and had genetically proven SAVI: gain-of-function TMEM173 mutations in the context of clinical features consistent with SAVI (vasculopathy, interstitial pulmonary disease, systemic inflammation).